The novel function of a key enzyme regulating tryptophan-NAD metabolism
The novel function of a key enzyme regulating tryptophan-NAD metabolism
批准号:
13660118
负责人:
EGASHIRA Yukari
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2003
中文摘要
在体外实验中,吡啶甲酸酯与免疫系统有关。另一方面,喹啉酸盐是一种强效的神经细胞内源性兴奋毒素。α-氨基-β-羧酸盐-ε-半醛脱羧酶(ACMSD; EC 4.1.1.45)是调节色氨酸-烟酸代谢的重要酶之一。ACMSD似乎能够直接影响吡啶酸盐和喹啉酸盐的生产。本研究探讨急性免疫刺激对大鼠ACMSD活性及mRNA表达的影响。RT-PCR结果显示,对照组和lps处理组大鼠肝脏和肾脏中均有ACMSD mRNA表达,而脑、肺、脾和胸腺中均无。对照组与LPS处理大鼠ACMSD活性及mRNA水平无显著差异。此外,我们还测量了大鼠饲喂亚油酸后色氨酸分解物喹啉酸的水平。饲粮中添加10%或20%亚油酸的大鼠肝脏ACMSD mRNA被强烈抑制,血清喹啉酸显著升高。这些结果表明ACMSD活性与色氨酸转化为喹啉酸的产量呈反比关系。
英文摘要
Picolinate has been implicated in immune system in vitro experiments. On the other hand, quinolinate is a potent endogenous excitotoxin of neuronal cells. α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD ; EC 4.1.1.45) is one of the important enzymes regulating tryptophan-niacin metabolism. ACMSD seems to be able to influence directly the production of picolinate and quinolinate. In this study, we investigated the effect of acute immune stimulation on ACMSD activity and mRNA expression in rats. ACMSD mRNA was expressed in the liver and kidney, but not in the brain, lung, spleen and thymus by RT-PCR in control and LPS-treated groups. There were no significant difference between control and LPS treated rats in ACMSD activity and mRNA. Moreover we measured the tryptophan catabolite quinolinic acid level in rats fed on linoleic acid. In rats fed with 10 or 20% linoleic acid diet, ACMSD mRNA in the liver was strongly suppressed and serum quinolinic acid was significantly increased as compared with the rats fed on a fat-free diet. These results suggest that there is an inverse relationship between ACMSD activity and the production of quinolinic acid converted from tryptophan.
期刊论文(14)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Fukuoka SI et al.: "Identification and expression of a cDNA encoding human alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD). A key enzyme for the tryptophan-niacine pathway and "quinolinate hypothesis""J. Biol. Chem.. 277・38. 35
Fukuoka SI 等人:“编码人 α-氨基-β-羧基粘康酸-ε-半醛脱羧酶 (ACMSD) 的 cDNA 的鉴定和表达。色氨酸-烟酸途径和“喹啉酸假说”的关键酶”J. Biol。化学.. 277・38.
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
江頭 祐嘉合, 笹原祥吾, 真田宏夫: "トリプトファン・ナイアシン代謝の鍵酵素α-アミノ-β-カルボキシムコン酸-ε-セミアルデヒド脱炭酸酵素(ACMSD)と免疫との関連"健康創造研究会誌. 3・1(in press). (2004)
Yukago Egashira、Shogo Sasahara、Hiroo Sanada:“色氨酸和烟酸代谢中的关键酶 α-氨基-β-羧基粘康酸-ε-半醛脱羧酶 (ACMSD) 与免疫之间的关系”健康创造研究会杂志 3。・1(正在出版)(2004)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Tanabe: "Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase."Biochem.J.. 361. 567-575 (2002)
A.Tanabe:“大鼠 2-氨基-3-羧基粘康酸-6-半醛脱羧酶的纯化和分子克隆。”Biochem.J.. 361. 567-575 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Tanabe: "Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes."J.Nutr.. 132. 1153-1159 (2002)
A.Tanabe:“大鼠肝脏 2-氨基-3-羧基粘康酸-6-半醛脱羧酶的表达受到高蛋白饮食和链脲佐菌素诱导的糖尿病的影响。”J.Nutr.. 132. 1153-1159 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
S.Fukuoka: "Identification and expression of a cDNA encoding human ACMSD : a key enzyme for the tryptophan-niacine pathway and quinolinate hypothesis."J.Biol.Chem.. 277. 35162-35167 (2002)
S.Fukuoka:“编码人 ACMSD 的 cDNA 的鉴定和表达:色氨酸烟酸途径和喹啉酸假说的关键酶。”J.Biol.Chem.. 277. 35162-35167 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 12 条
Study on the regulatory mechanisms of neurodegenelation by tryptophan key enzymes
-
批准号:23580158
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.58万
-
财政年份:2011
-
负责人:EGASHIRA Yukari
-
依托单位:
The role of tryptophan-niacin key enzymes in brain's immune system
-
批准号:20580122
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.08万
-
财政年份:2008
-
负责人:EGASHIRA Yukari
-
依托单位:
A novel function of tryptophan key enzyme in the brain and its regulation mechanism
-
批准号:17580105
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:2005
-
负责人:EGASHIRA Yukari
-
依托单位:
海外基金